Fig. 3From: Over-prescription of short-acting β2-agonists remains a serious health concern in Kenya: results from the SABINA III studySABA purchases and prescriptions in patients with asthma. OTC, Over-the-counter; SABA, Short-acting β2-agonistBack to article page